Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Sex differences in treatment strategy and adverse outcomes among patients 75 and older with atrial fibrillation in the MarketScan database

BMC Cardiovascular Disorders(2021)10.1186/s12872-021-02419-2Source: DataRank Database

Sex differences in treatment strategy and adverse outcomes among patients 75 and older with atrial fibrillation in the MarketScan database is a research paper published in BMC Cardiovascular Disorders (2021). On theSindex it has a DataRank of 0. It has been cited 15 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)OA: goldTopics (52)IDs (PubMed, PMC)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

J’Neka S. Claxton ORCID,Pamela L. Lutsey ORCID,Richard F. MacLehose ORCID,Lin Y. Chen ORCID,Alanna M. Chamberlain ORCID

Live enrichment

PubMed:34915858 PMC:PMC8679994

National Institutes of Health

Grant: R21AG058445

National Institutes of Health

Grant: K24HL148521

National Institutes of Health

Grant: R01HL122200

American Heart Association

Grant: 16EIA2641001

American Heart Association-American Stroke Association

Grant: 16EIA26410001

National Institutes of Health

Grant: 1R21AG058445-01

Atrial fibrillation treatment in older adults

National Institutes of Health

Grant: 1R01HL122200-01A1

Comparative Effectiveness of Oral Anticoagulants in Atrial Fibrillation

National Institutes of Health

Grant: 5K24HL148521-02

Mentoring in patient-oriented atrial fibrillation and cardiovascular research

goldLicense: cc-by

publisherhttps://bmccardiovascdisord.biomedcentral.com/counter/pdf/10.1186/s12872-021-02419-2

publisherhttps://link.springer.com/content/pdf/10.1186/s12872-021-02419-2.pdf

publisherhttps://link.springer.com/article/10.1186/s12872-021-02419-2/fulltext.html

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8679994

repositoryhttps://doaj.org/article/0be4380207714c18a9bd3c4b4ce73ef8

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

HumansAtrial FibrillationHemorrhageAnti-Arrhythmia AgentsAnticoagulantsTreatment OutcomeRisk AssessmentRisk FactorsAge FactorsSex FactorsHeart RateTime FactorsDatabases, FactualAgedAged, 80 and overUnited StatesFemaleMaleStrokeHealth Status DisparitiesHealthcare Disparities

Keywords

AnticoagulationAtrial fibrillationStrokeSex differencesRhythm ControlMajor BleedingRate ControlHeat FailureMaleTime FactorsDatabases, FactualHemorrhageRisk AssessmentSex FactorsHeart RateRisk FactorsDiseases of the circulatory (Cardiovascular) systemHumansHealthcare DisparitiesAgedAged, 80 and overResearchAge FactorsAnticoagulantsHealth Status DisparitiesTreatment OutcomeRC666-701FemaleAnti-Arrhythmia Agents

Sustainable Development Goals

SDG 3: 3. Good healthSDG 10: 10. No inequality